Enter your keywords

NICE TA875; Semaglutide for managing obesity: A briefing for ICSs  

In March 2023 NICE published TA875: Technology Appraisal guidance for semaglutide (Wegovy®) for managing overweight and obesity. The guidance recommends semaglutide as an option for weight management when prescribed by a specialist service alongside a reduced-calorie diet and increased physical activity in adults if they meet the criteria specified. This briefing aims to provide advice […]

Polypharmacy & Overprescribing: Opioid population health management

In recent years, there has been increasing concern regarding the overprescribing of opioids and associated harms. The RDTC has produced a series of publications as part of the Polypharmacy and Overprescribing theme reviewing opioid prescribing: Each publication includes considerations and interventions for medicines optimisation teams and health systems. To avoid duplication across this series of […]

Polypharmacy & Overprescribing: Opioid patient demographics

In recent years, there has been increasing concern regarding the overprescribing of opioids and associated harms. The RDTC has produced a series of publications as part of the Polypharmacy and Overprescribing theme reviewing opioid prescribing: Each publication includes considerations and interventions for medicines optimisation teams and health systems. To avoid duplication across this series of […]

Polypharmacy & Overprescribing: Opioid patient populations

In recent years, there has been increasing concern regarding the overprescribing of opioids and associated harms. The RDTC has produced a series of publications as part of the Polypharmacy and Overprescribing theme reviewing opioid prescribing: Each publication includes considerations and interventions for medicines optimisation teams and health systems. To avoid duplication across this series of […]

Pain Management

This report looks at prescribing trends in primary care in relation to Pain Management at ICB and Sub Integrated Board location (SICBl) with particular focus on Opioid and Non-opioid analgesics, Neuropathic pain, Antimigraine drugs and Osteoarthritis. If you have any queries about the content of the report please contact us at nuth.nyrdtc.rxsupp@nhs.net Frequency Bi-annually Data […]

Drugs for Dementia

This report looks at prescribing trends in primary care for Drugs for Dementia at SICBl and ICB level with particular focus on low strength antipsychotics. Prescribing data is weighted with QoF registers. If you have any queries about the content of the report please contact us at nuth.nyrdtc.rxsupp@nhs.net Frequency Quarterly Data Period January 2020 to […]

Optimising the use of morphine 10mg/5mL oral solution in primary care (Update)

Opioids are effective for acute pain and pain at the end of life, but there is little evidence of their effectiveness for long term pain. This document supports primary care teams to review patients receiving regular large quantities of morphine 10mg/5mL oral solution and includes advice on how these patients could be managed. This publication […]

Antidepressant drugs

This report looks at prescribing trends in primary care for Antidepressant drugs at CCG and STP level with particular focus on first choice antidepressant prescribing and exploration of associations between prescribing and improving access to psychological therapies. If you have any queries about the content of the report please contact us at nuth.nyrdtc.rxsupp@nhs.net Frequency Annually […]